Filing Flows › Precigen (PGEN) › Q1 2025
Precigen (PGEN) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 14, 2025
Precigen (PGEN) reported revenue of $1.3M for the first quarter 2025 (Q1 2025).
Precigen, Q1 2025: revenue $1.3M, net loss $54.2M, operating cash flow −$16.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | — | — |
| Operating profit | −$22.6M | — | — |
| Net earnings | −$54.2M | — | — |
| Operating cash flow | −$16.3M | — | — |
What changed
Revenue was $1.3M in Q1 2025.
Operating costs exceeded revenue by $22.6M, an operating margin of -1685.0%. The quarter ended with a net loss of $54.2M. Net interest and other expense of $31.6M was the main reason.
Operating cash flow was −$16.3M. Non-cash charges added back $629K of depreciation and amortization and $2.7M of share-based compensation. Working capital and other items added $34.5M. Capital expenditures of $622K exceeded it, leaving free cash flow of −$16.9M.
Questions
What was Precigen's revenue in the first quarter 2025?
Precigen (PGEN) reported revenue of $1.3M for the first quarter 2025 (Q1 2025).
Source: Precigen 10-Q on SEC EDGAR.